Page last updated: 2024-11-01

nimodipine and Aortic Coarctation

nimodipine has been researched along with Aortic Coarctation in 1 studies

Nimodipine: A calcium channel blockader with preferential cerebrovascular activity. It has marked cerebrovascular dilating effects and lowers blood pressure.
nimodipine : A dihydropyridine that is 1,4-dihydropyridine which is substituted by methyl groups at positions 2 and 6, a (2-methoxyethoxy)carbonyl group at position 3, a m-nitrophenyl group at position 4, and an isopropoxycarbonyl group at position 5. An L-type calcium channel blocker, it acts particularly on cerebral circulation, and is used both orally and intravenously for the prevention and treatment of subarachnoid hemorrhage from ruptured intracranial aneurysm.

Aortic Coarctation: A birth defect characterized by the narrowing of the AORTA that can be of varying degree and at any point from the transverse arch to the iliac bifurcation. Aortic coarctation causes arterial HYPERTENSION before the point of narrowing and arterial HYPOTENSION beyond the narrowed portion.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Zheng, YM1
Xie, CH1
Gong, FQ1

Other Studies

1 other study available for nimodipine and Aortic Coarctation

ArticleYear
Moyamoya disease associated with aortic coarctation.
    World journal of pediatrics : WJP, 2014, Volume: 10, Issue:4

    Topics: Angioplasty, Balloon, Coronary; Anticoagulants; Aortic Coarctation; Aspirin; Calcium Channel Blocker

2014